AZAD
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

AZAD Trademark

Serial Number: 79073708 • Registration: 3832147

AZAD is a trademark filed by AZAD Pharmaceutical Ingredients AG on January 8, 2009. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

AZAD Pharmaceutical Ingredients AG (3 trademarks)

Durachweg 15

Entity Type: 99

MIBA Holding AG (2 trademarks)

Friedbergstrasse 68
Schaffhausen CH8200 , CH

Entity Type: 99

Trademark Details

Filing Date

January 8, 2009

Registration Date

August 10, 2010

Published for Opposition

May 25, 2010

Cancellation Date

January 8, 2019

Goods & Services

[ Pharmaceutical products, namely, pharmaceutical products and preparations for the treatment of cancer, ophthalmic, cardiovascular, neurological, respiratory, digestive and inflammatory disease; veterinary products, namely, veterinary preparations for the treatment of cancer, ophthalmic, cardiovascular, neurological, respiratory, digestive and inflammatory diseases; sanitary preparations for medical purposes; dietetic foods adapted for medical use; adjuvants for medical purposes, namely, recombinant proteins and vaccines for human purposes and for surgical and non-surgical purposes; analgesics; vermifuges; antibiotics; biological preparations for medical purposes, namely, biological preparations to produce medicines for human or veterinary use; chemical preparations for pharmaceutical purposes, namely, bismuth preparations for pharmaceutical purposes; potassium preparations for pharmaceutical purposes; chemical reagents for medical or veterinary purposes; chemico-pharmaceutical preparations, namely, chemical preparations for sanitary use, pharmaceutical preparations for use in chemotherapy; ferments for medical or veterinary use; hormones for medical purposes; medicinal infusions extracted from natural plants for medical and veterinary purposes; medicines for dental purposes, namely, topical and surgical anesthetics; medicines for human purposes, namely, medicines for the treatment of cancer, ophthalmic, cardiovascular, neurological, respiratory, digestive and inflammatory disease; pharmaceutical preparations, namely, for the treatment of cancer, ophthalmic, cardiovascular, neurological, respiratory, digestive and inflammatory disease; pills for pharmaceutical purposes, namely, pills containing pharmaceutical products and preparations for the treatment of cancer, ophthalmic, cardiovascular, neurological, respiratory, digestive and inflammatory disease; radiological contrast media for medical purposes; steroids ]

[ Medical services; veterinary services ]

Scientific and technological services, namely, scientific research, technological consultation and research, all in the field of chemico-pharmaceutical preparations; industrial analysis and research services in the field of chemico-pharmaceutical preparations; biological research; chemical analysis; chemical research; chemistry services, namely chemistry consultation, research in the field of chemistry; quality control for others in the field of human and veterinary pharmaceutical preparations; quality control for others; research and development of new products for third parties

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Aug 9, 2019 DENC
DEATH OF INTERNATIONAL REGISTRATION
Aug 9, 2019 DETH
PARTIAL INVALIDATION PROCESSED BY THE IB
May 20, 2017 INNP
GENERIC MADRID TRANSACTION SENT TO IB
Jan 21, 2017 XXSS
GENERIC MADRID TRANSACTION CREATED
Jan 21, 2017 XXCR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 24, 2016 INPR
NEW REPRESENTATIVE AT IB RECEIVED
Mar 18, 2016 NREP
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Feb 24, 2016 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
Feb 24, 2016 71.P
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Feb 22, 2016 EROP
POST REGISTRATION ACTION MAILED - SEC.71
Jan 7, 2016 PR71
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 6, 2016 APRE
TEAS SECTION 71 RECEIVED
Nov 24, 2015 ES71
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 3, 2015 ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
Mar 26, 2012 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 4, 2010 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Nov 12, 2010 FICS
FINAL DISPOSITION PROCESSED
Nov 12, 2010 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 10, 2010 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 10, 2010 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 25, 2010 NPUB
PUBLISHED FOR OPPOSITION
May 25, 2010 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 19, 2010 PREV
ASSIGNED TO LIE
Apr 19, 2010 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 2, 2010 CNSA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 25, 2010 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 25, 2010 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 25, 2010 TCCA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 25, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 25, 2010 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 25, 2010 TROA
REFUSAL PROCESSED BY IB
Dec 18, 2009 RFNT
APPLICATION FILING RECEIPT MAILED
Nov 10, 2009 MAFR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 9, 2009 RFCS
REFUSAL PROCESSED BY MPU
Nov 9, 2009 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 9, 2009 RFCR
NON-FINAL ACTION WRITTEN
Nov 6, 2009 CNRT
ASSIGNED TO EXAMINER
Nov 4, 2009 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 4, 2009 NWOS
LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Oct 29, 2009 LIMS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 29, 2009 REPR